(4,6-Dichloropyridin-2-yl)methanamine

Catalog No.: 
ACOZBT872
CAS No.: 
1060815-16-8
Molecular Formula: 
C6H6Cl2N2
Molecular Weight: 
177.03
(4,6-Dichloropyridin-2-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$107.00In stockInquiry
250mg95%$215.00In stockInquiry
1g95%$518.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4,6-Dichloropyridin-2-yl)methanamine
IUPAC Name(4,6-dichloropyridin-2-yl)methanamine
MDL No.MFCD10698619
Molecular FormulaC6H6Cl2N2
Molecular Weight177.03
SMILESNCC1=NC(Cl)=CC(Cl)=C1
InChI KeyMLZPDLJHFHXQHI-UHFFFAOYSA-N
SynonymC-(4,6-Dichloro-pyridin-2-yl)-MethylaMine;(4,6-dichloropyridin-2-yl)methanamine;2-Pyridinemethanamine, 4,6-dichloro-;4,6-Dichloro-2-pyridinemethanamine;(4,6-Dichloropyridin-2-yl)methanamine - [D89676]
CAS No.1060815-16-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOZBT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRAM253 route compound structure diagram
    ACBRAM25340314-71-4In Stock
  2. Then
  3. ACOZBT872 route product structure diagram
    ACOZBT8721060815-16-8In Stock
Inquiry

2. ACOZBT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOZBT872 route product structure diagram
    ACOZBT8721060815-16-8In Stock
Inquiry

3. ACOZBT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOZBT872 route product structure diagram
    ACOZBT8721060815-16-8In Stock
Inquiry

Comments (0)